Phospho-Catenin- beta (Thr41/Ser45) Antibody

Phospho-Catenin- beta (Thr41/Ser45) Antibody

• DataSheet
• Material Safety Data Sheets (MSDS)

Peptide affinitypurifiedRabbitPolyclonalAntibody(Pab)

WB

Human, Mouse, Rat

CTNNB antibody; Catenin beta-1 antibody; Beta-catenin antibody; CTNNB1 antibody; CTNNB antibody

Rabbit IgG

Phospho-Catenin- beta (Thr41/Ser45) Antibody detects endogenous levels of Catenin- beta only when phosphorylated at Threonine 41/Serine 45

Polyclonal

Peptide affinity purified.Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

Short term 4°C, long term aliquot and store at -20°C, avoid freeze thaw cycles. Store undiluted.

WB: 1:500-1:2000

Key downstream component of the canonical Wnt signaling pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2, APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its subsequent degradation by the proteasome. In the presence of Wnt ligand, CTNNB1 is not ubiquitinated and accumulates in the nucleus, where it acts as a coactivator for transcription factors of the TCF/LEF family, leading to activate Wnt responsive genes. Involved in the regulation of cell adhesion. Acts as a negative regulator of centrosome cohesion. Involved in the CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization. Blocks anoikis of malignant kidney and intestinal epithelial cells and promotes their anchorage-independent growth by down-regulating DAPK2. Disrupts PML function and PML-NB formation by inhibiting RANBP2-mediated sumoylation of PML (PubMed:17524503, PubMed:18077326, PubMed:18086858, PubMed:18957423, PubMed:21262353, PubMed:22647378, PubMed:22699938, PubMed:22155184). Promotes neurogenesis by maintaining sympathetic neuroblasts within the cell cycle (By similarity).